CARDIFF ONCOLOGY
Cardiff Oncology is a clinical-stage oncology therapeutics company developing drugs that target cell division for the treatment of leukemias, lymphomas, and solid tumor cancers. It has a broad intellectual property and proprietary technology to measure circulating tumor DNA (ctDNA) in urine and blood to identify and quantify clinically actionable markers for predicting response to cancer therapies. The company offers its PCM technology at its CLIA/CAP-accredited laboratory and plans to continue to vertically integrate its PCM technology with precision cancer therapeutics. Cardiff Oncology (formerly known as Trovagene) was founded in 1999 and is headquartered in San Diego, California.
CARDIFF ONCOLOGY
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
1999-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.cardiffoncology.com
Total Employee:
11+
Status:
Active
Contact:
+1 858-952-7570
Email Addresses:
[email protected]
Total Funding:
80.46 M USD
Technology used in webpage:
SPF Google Font API Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail IPv6 Google Maps GoDaddy DNS Google PHP 7
Similar Organizations
ABT Molecular Imaging
ABT Molecular Imaging develops a production platform to generate unit doses of molecular imaging drugs for PET scanning at the point of use.
ADMA Biologics
ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases.
Apollo Hospitals Enterprise
Apollo Hospitals is a premium multi-specialty hospital of India and is one of the largest integrated healthcare groups.
Atonarp
Atonarp combines electronics and data processing algorithms for chemical composition analysis.
Tarveda Therapeutics
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
CellPhire
Cellphire has developed a proprietary method for the stabilization of blood in the dry state
CVRx
CVRx is a medical device company developing implantable technology for the treatment of high blood pressure.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Vero Biotech
Vero Biotech is a biopharmaceutical company developing products to address the medical needs of patients with pulmonary, cardiac diseases.
GluMetrics
GluMetrics, a medical company based in Irvine, California, develops tools that enable clinicians to implement a care paradigm for patients.
Kipu Health
SaaS platform for behavioral health and addiction treatment centers providing EHR, patient engagement and RCM solutions.
NanoString Technologies
NanoString Technologies provides a life science tools platform for a variety of basic research, translational medicine and IVD applications.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Omega Diagnostics
Omega Diagnostics provides IVD products for use in hospitals, blood banks, clinics, and laboratories.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Thyrocare Technologies
Thyrocare Technologies Limited is India's first fully automated diagnostic laboratory.
Current Employees Featured
Founder
Stock Details
Investors List
Pfizer Breakthrough Growth Initiative
Pfizer Breakthrough Growth Initiative investment in Post-IPO Equity - Cardiff Oncology
Acorn Bioventures
Acorn Bioventures investment in Post-IPO Equity - Cardiff Oncology
CAM Capital
CAM Capital investment in Post-IPO Equity - Cardiff Oncology
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Cardiff Oncology
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Cardiff Oncology
Key Employee Changes
Official Site Inspections
http://www.cardiffoncology.com Semrush global rank: 4.11 M Semrush visits lastest month: 2.94 K
- Host name: 172.67.29.74
- IP address: 172.67.29.74
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
